Peptide record

TPDB41458

Peptide6 Gonearrestide Anticancer standard
12 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB41458
Peptide6 Gonearrestide
Anticancer
Cancer-related peptides
CancerPPD 2.0
standard
No
A 12-aa standard natural anticancer peptide sequence curated from CancerPPD 2.0, with an available 3D structural model.
Sequence
KLSAIISKIRDE
Physicochemical Analysis
C60H109N17O19
NCQGHMFPTWYV
I
1372.63
9.88
3
2
5
+1
4.64
-0.150
138.33
Mammalian: 1.3 hour Yeast: 3 min E.coli: 2 min
0
0.00
2
Residue Composition
number
1
A
1
R
0
N
1
D
0
C
1
E
0
Q
0
G
0
H
3
I
1
L
2
K
0
M
0
F
0
P
2
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 1 R: 1 N: 0 D: 1 C: 0 E: 1 Q: 0 G: 0 H: 0 I: 3 L: 1 K: 2 M: 0 F: 0 P: 0 S: 2 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
12
C60H109N17O19
1372.63
9.88
+1
4.64
-0.150
Free
L
Linear
Free
Anticancer
Androctonus australis
Evidence Records 5 records
Evidence 1 Activity

Activity

Not Available
Anticancer

Target

Colon Cancer
HCT-116
Colon

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2018

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

Not Available
Anticancer

Target

Colon Cancer
DLD-1
Colon

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2018
Evidence 3 Activity

Activity

Not Available
Anticancer

Target

Colon Cancer
HKe-3
Colon

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2018
Evidence 4 Activity

Activity

Not Available
Anticancer

Target

Colon Cancer
Dks8
Colon

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2018
Evidence 5 Activity

Activity

Not Available
Anticancer

Target

Brain tumor
U-251
Brain

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2018